Literature DB >> 27365885

Mammary-type myofibroblastoma with the nephrotic syndrome.

Gates B Colbert1, Preksha Vankawala1, Michael B Kuperman1, Robert G Mennel1.   

Abstract

We describe a 23-year-old white man who presented with anasarca and a new periumbilical mass. He had preserved kidney function and laboratory findings consistent with nephrotic syndrome, including 9.7 g/day albuminuria. Serum serologies were positive for anti-SSa and anti-SSb and low complements but were negative for antinuclear antibody. Pathologic findings of the abdominal mass showed a mammary-type myofibroblastoma. A kidney biopsy revealed a diffuse proliferative and membranous immune-mediated glomerulonephritis with 10% interstitial fibrosis. This is a novel case of mammary-type myofibroblastoma associated with nephrotic syndrome mimicking a proliferative lupus pattern.

Entities:  

Year:  2016        PMID: 27365885      PMCID: PMC4900783          DOI: 10.1080/08998280.2016.11929452

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  Renal-limited 'lupus-like' nephritis.

Authors:  Ana Huerta; Andrew S Bomback; Vassilis Liakopoulos; Amudha Palanisamy; M Barry Stokes; Vivette D D'Agati; Jai Radhakrishnan; Glen S Markowitz; Gerald B Appel
Journal:  Nephrol Dial Transplant       Date:  2011-12-29       Impact factor: 5.992

Review 2.  Complications of the nephrotic syndrome and their treatment.

Authors:  R J Crew; J Radhakrishnan; G Appel
Journal:  Clin Nephrol       Date:  2004-10       Impact factor: 0.975

3.  Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor.

Authors:  E S Wargotz; S W Weiss; H J Norris
Journal:  Am J Surg Pathol       Date:  1987-07       Impact factor: 6.394

4.  The association of cancer and the nephrotic syndrome.

Authors:  J C Lee; H Yamauchi; J Hopper
Journal:  Ann Intern Med       Date:  1966-01       Impact factor: 25.391

5.  Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.

Authors:  Brad H Rovin; Richard Furie; Kevin Latinis; R John Looney; Fernando C Fervenza; Jorge Sanchez-Guerrero; Romeo Maciuca; David Zhang; Jay P Garg; Paul Brunetta; Gerald Appel
Journal:  Arthritis Rheum       Date:  2012-01-09

Review 6.  Membranous nephropathy and malignancy.

Authors:  Laurence H Beck
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

7.  Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Authors:  Gerald B Appel; Gabriel Contreras; Mary Anne Dooley; Ellen M Ginzler; David Isenberg; David Jayne; Lei-Shi Li; Eduardo Mysler; Jorge Sánchez-Guerrero; Neil Solomons; David Wofsy
Journal:  J Am Soc Nephrol       Date:  2009-04-15       Impact factor: 10.121

8.  Mammary-type Myofibroblastoma: Clinicopathologic Characterization in a Series of 143 Cases.

Authors:  Brooke E Howitt; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

Review 9.  Glomerular diseases and cancer: evaluation of underlying malignancy.

Authors:  Antonello Pani; Camillo Porta; Laura Cosmai; Patrizia Melis; Matteo Floris; Doloretta Piras; Maurizio Gallieni; Mitchell Rosner; Claudio Ponticelli
Journal:  J Nephrol       Date:  2015-10-26       Impact factor: 3.902

  9 in total
  1 in total

Review 1.  Mammary-type myofibroblastoma of the psoas.

Authors:  Kamran Khan; Arun A Mavanur
Journal:  BMJ Case Rep       Date:  2016-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.